Dr. Lisa Tannock, MD

• Endocrinology, Diabetes & Metabolism

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Wa

  Fellowship Hospital, 2000

• University Toronto

  Internship Hospital, 1995

• University Of Toronto, Fac Med

  Medical School, 1994

• Circadian disruption with constant light exposure exacerbates atherosclerosis in maleApolipoproteinE-deficient mice, 2020-06-18

• Elevated circulating TGF-ß is not the cause of increased atherosclerosis development in biglycan deficient mice, 2017-11-10

• Chronic environmental circadian disruption increases atherosclerosis and dyslipidemia in female, but not male,ApolipoproteinE-deficient mice 10.3389/fphys.2023.1167858, 2023-03-29

• HDL remodeling during the acute phase response, 2008-11-13

• Role of Serum Amyloid A in Atherosclerosis, 2020-05-05

• Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice, 2019-09-04

• Serum amyloid A3 is pro-atherogenic, 2017-11-17

• SAA is Found on ApoB-Containing Lipoproteins in Obese Diabetic Humans, 2012-10-23

• Vascular proteoglycans and atherosclerosis: Not over yet, 2014-09-28

• Serum Amyloid A is an exchangeable apolipoprotein, 2018-06-21

• Endogenous Androgen Deficiency Enhances Diet-Induced Hypercholesterolemia and Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice, 2012-09-13

• Thiol Oxidative Stress Induced by Metabolic Disorders Amplifies Macrophage Chemotactic Responses and Accelerates Atherogenesis and Kidney Injury in LDL Receptor-Deficient Mice, 2009-07-10

• Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular Diseases, 2021-12-15

• Decreased body fat, elevated plasma transforming growth factor-ß levels, and impaired BMP4-like signaling in biglycan-deficient mice, 2012-08-23

• A Murine Model of Obesity with Accelerated Atherosclerosis, 2009-06-04

• Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection, 2014-08-02

• Durability of Glycemic Control using U-500 Insulin, 2011-11-15

• Creation of an Institutional Semi-Independent Data Monitoring Committee, 2019-07-01

• Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein, 2023-03-31

• Adipocyte-derived serum amyloid A promotes angiotensin II-induced abdominal aortic aneurysms in obese C57BL/6J mice, 2022-03-28

• Clinical Efficacy and Patient Satisfaction with U-500 Insulin Use, 2010-03-11

• Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications, 2022-04-18

• Increased atherosclerosis in mice with increased vascular biglycan content, 2014-04-15

• Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL bindingin vitroand aortic lipid depositionin vivo, 2009-09-14